HIV Clinical Research Unit
Overview
The Specialty Care Center (SCC) at the FDOH in Hillsborough County is a state-of-the-art clinical facility providing the highest quality care for sexual preventative health and to persons living with HIV. The Center is Ryan White funded for medical, dental and pharmacy services. USF Infectious Disease clinical research team at the Clinical Research Unit (CRU), founded by Dr. Jeffrey Nadler in 1995, is comprised of highly qualified clinical researchers and staff. The CRU offers access to innovative translational, clinical, and behavioral research to prevent HIV and other infectious diseases and aims to improve the quality of life of those living with HIV.
To enroll, call: (813) 307-8067
You may qualify for free treatment. We send automatic updates when new studies become available at the USF Health HIV Clinical Research Unit. Your information will be kept confidential and emails are discreet.
Doctors
-
Charurut Somboonwit, MD, FACPCharurut Somboonwit, MD, FACPProfessor
USF Division of Infectious Disease
Director, Communicable Diseases -
Beata Casanas, DO, FACP, FIDSABeata Casanas, DO, FACP, FIDSAProfessor
USF Division of Infectious Disease
Director, TB, Refugee & Immunization Clinic -
Ambika Eranki, MDAmbika Eranki, MDAssistant Professor
USF Division of Infectious Disease
Faculty Investigator -
Jacqueline Sherbuk, MDJacqueline Sherbuk, MDAssistant Professor
USF Division of Infectious Disease
Faculty Investigator
Clinical Research Unit
-
Madison Ball, BSMadison Ball, BSResearch Support Specialist
-
Hyacinth Burrowes, CPT, CRA-USF/BasicHyacinth Burrowes, CPT, CRA-USF/BasicResearch Support Specialist
-
Julian Guerrero, BS, CRA-USF/BasicJulian Guerrero, BS, CRA-USF/BasicResearch Support Specialist
-
Avennette Pinto, MBBSAvennette Pinto, MBBSClinical Research Associate
-
Carolina Plata BS, CRA-USF/BasicCarolina Plata BS, CRA-USF/BasicSocial & Behavioral Researcher
Current HIV Research
PI | Protocol | Sponsor |
---|---|---|
Casanas | A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus(+) Rilpivivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants with HIV-1 Who are Virologically Suppressed (SOLAR) (Protocol 213500) | Viiv Healthcare |
Somboonwit | Health Outcomes and Cognitive Effects of Marijuana Use among Persons Living with HIV/AIDS (MAPLE) | University of Florida |
Somboonwit | Randomized Trial to Prevent Vascular Events in HIV (A5332 REPRIEVE - The REPRIEVE Study) | DAIDS |
Somboonwit | The Florida Cohort to Monitor and Improve Health Outcomes (UF Cohort) | University of Florida |
Somboonwit | Strategic Timing of Antiretroviral Treatment (START) | University of Minnesota |
Somboonwit (Duke) | Consequences of Marijuana Use on Inflammatory Pathways in HIV NIH/NIDA -Infected Youth | NIH/NIDA |